Versant Venture Management, LLC
•CIK: 1560009•Filing: Q4 2025
**Versant Venture Management, LLC** manages $151M across a concentrated portfolio of seven positions. The fund exhibits significant conviction in its top holdings, led by GLUE, representing $68.7M, and LENZ at $42.5M. Further substantial allocations include JBIO ($23.5M), maintaining a high degree of concentration risk. This structure suggests a focused, high-conviction approach targeting specific sector opportunities.
Total AUM
$151.1M
QoQ Performance
-28.9%
Positions
7
Top 10 Concentration
100.0%
Latest Filing
Q4 2025
Top Holdings Allocation
GLUE
LENZ
JBIO
CRSP
GLUE45.5%
LENZ28.1%
JBIO15.6%
CRSP5.2%
CTNM4.1%
SKYE1.0%
OVASUSD0.5%
📈 Biggest Buys
No new positions or increases this quarter
📉 Biggest Sells
GLUE
Monte Rosa Therapeutics, Inc.
-22.5%
45.5% of portfolio
Sector Breakdown
Other100.0%
🚪 Exited Positionssold since Q3 2025
—
Adverum Biotechnologies, Inc.
SOLD
$2.3M
Changes from Q3 2025
↓1 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023